COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in the fall of 2024." The organization recommends a six-month interval between COVID vaccines, "with a minimum of three months from the last dose."
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
The Centers for Disease Control and Prevention says that the Food and Drug Administration has ended a program that provided ...
With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...
The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...
Moderna said the Spikevax 2024-2025 formula is expected to be available across the U.S. in the days immediately following approval. Pfizer also said shipping will begin immediately. Thursday ...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
Spikevax 2024-2025 formula expected to be available in pharmacies and care settings across the U.S. in the days immediately following approval CAMBRIDGE, MA / ACCESSWIRE / August 22, 2024 ...
Specifically, in 2021-2023, Moderna invested proceeds from its pandemic-era vaccine sales into building a diverse pipeline and established the market for its COVID-19 vaccine, Spikevax®. In ...
Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback